MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ABUS — Arbutus Biopharma Corporation Common Stock
NasdaqArbutus Biopharma Corporation Common Stock
$4.56
-0.22(-4.60%)
- O
- 4.77
- H
- 4.78
- L
- 4.51
- V
- 16.62M
⏱️ End-of-day dataAs of Oct 1, 2026
ABUS — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $23.71M | $18.01M | $22.41M | $37.41M | $37.08M | $36.33M |
| Other Short Term Investments | $71.52M | $73.46M | $71.29M | $60.68M | $75.63M | $86.29M |
| Accounts Receivable | $1.31M | $1.45M | 905,000.00 | $1.02M | $1.18M | $2.41M |
| Other Receivables | $17.87M | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | $1.73M | $1.54M | $2.83M | $4.01M | $2.92M | $2.28M |
| Total Current Assets | $27.70M | $94.46M | $97.44M | $10.31M | $11.68M | $12.73M |
| Accumulated Depreciation | -224,000.00 | -213,000.00 | $-13.35M | $-13.31M | $-13.33M | $-13.00M |
| Other Non Current Assets | 131,000.00 | 130,000.00 | 131,000.00 | N/A | 34,000.00 | 34,000.00 |
| Total Non Current Assets | 153,000.00 | 162,000.00 | 268,000.00 | 148,000.00 | 202,000.00 | $4.39M |
| Total Assets | $27.72M | $94.62M | $97.71M | $10.33M | $11.70M | $13.17M |
| Accounts Payable | $1.46M | $1.17M | $1.01M | $1.32M | $2.24M | $2.32M |
| Accrued Expenses | $2.77M | $3.65M | $2.88M | $2.42M | $3.90M | $5.25M |
| Short Term Debt | 631,000.00 | 547,000.00 | 531,000.00 | 514,000.00 | 563,000.00 | 483,000.00 |
| Other Current Liabilities | 245,000.00 | 640,000.00 | 763,000.00 | 768,000.00 | $5.96M | N/A |
| Total Current Liabilities | $5.11M | $6.01M | $5.18M | $5.02M | $19.43M | $15.62M |
| Long Term Debt | 0.00 | 199,000.00 | 391,000.00 | 575,000.00 | 626,000.00 | 806,000.00 |
| Other Non Current Liabilities | $11.88M | $11.84M | $14.74M | $14.69M | $14.93M | $15.05M |
| Total Non Current Liabilities | $11.88M | $12.04M | $15.13M | $15.27M | $18.42M | $18.72M |
| Total Liabilities | $16.99M | $18.04M | $20.31M | $20.29M | $37.85M | $34.34M |
| Common Stock | $144.45M | $142.14M | $141.86M | $141.71M | $141.63M | $141.00M |
| Retained Earnings | $-121.04M | $-138.01M | $-137.63M | $-136.86M | $-137.11M | $-134.66M |
| Other Shareholders Equity | $-48.20M | $-48.10M | $-48.13M | $-48.19M | $-48.17M | $-48.13M |
| Total Shareholders Equity | $26.02M | $76.58M | $77.40M | $82.98M | $79.16M | $97.37M |
| Additional Paid In Capital | $74.26M | $83.32M | $83.28M | $82.63M | $82.09M | $82.05M |
| Properties | N/A | 0.00 | $13.48M | $13.46M | $13.49M | $8.29M |
| Machinery Furniture Equipment | N/A | 245,000.00 | N/A | N/A | N/A | 477,000.00 |
| Leases | N/A | 0.00 | N/A | N/A | N/A | $8.59M |
| Deferred Revenue | N/A | 0.00 | 0.00 | 0.00 | $6.76M | $7.57M |
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | 0.00 |